IP Verse

New Use - EP3038654B1

PatentPatent Analysis

EP3038654

NOVARTIS
Application Number
EP14761702A
Filing Date
Aug 26, 2014
Status
Revoked
Oct 15, 2024
Grant Date
Oct 30, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP4321157B1
EP3487881B1

Bibliography

The patent EP3038654B1 was granted to Novartis on Oct 30, 2019 following the initial filing on Aug 26, 2014 under the application number EP14761702A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERJul 30, 2020ADMISSIBLE
BETAPHARM ARZNEIMITTELJul 30, 2020ADMISSIBLE
KRKAJul 30, 2020ADMISSIBLE
POLPHARMAJul 30, 2020ADMISSIBLE
TEVA PHARMACEUTICALSJul 30, 2020ADMISSIBLE
KRAUS & LEDERER PARTGMBBJul 28, 2020ADMISSIBLE
ZENTIVAJul 23, 2020ADMISSIBLE
SYNTHONJul 17, 2020ADMISSIBLE
GENERICS UKJul 6, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents